News

Roche announced new OCREVUS (ocrelizumab) data that show its benefit on disease progression and cognitive outcomes in primary progressive multiple sclerosis (PPMS) and secondary…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and has granted Priority Review for…
Read More...

CanSino Biologics Inc. announced that the National Medical Products Administration of China granted approval for the clinical trial application of its COVID-19 mRNA vaccine in China.…
Read More...

SELLAS Life Sciences Group, Inc. a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, and GenFleet…
Read More...

Opioid use disorder is a serious public health issue in the United States and throughout the world. The Centers for Disease Control and Prevention estimates that the total "economic…
Read More...

Ono Pharmaceutical Co., Ltd. announced that it has exercised its option to enter into a development and license agreement with Numab Therapeutics AG for a multispecific antibody…
Read More...

Novartis today announced that the European Commission (EC) has approved Beovu (brolucizumab) 6 mg for the treatment of visual impairment due to diabetic macular edema (DME). Today’s…
Read More...

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced submission of its request to expand…
Read More...

Receptor Life Sciences (RLS), a pharmaceutical company developing innovative therapies to address central nervous system disorders, announced the U.S. Food and Drug Administration (FDA)…
Read More...

CytoDyn Inc. a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced that the U.S. Food and Drug…
Read More...

Neuron23 Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases, announced it has closed a…
Read More...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. and its affiliates, has reached an agreement with the Attorney General of Florida that settles the state’s…
Read More...

Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced today that the companies are unveiling Xpert Alliance, a…
Read More...

Pfizer Inc. and BioNTech SE  announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use of their COVID-19 vaccine to include a second booster dose in…
Read More...

Thermo Fisher Scientific launched the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform that delivers results in as…
Read More...

Sanofi and IGM Biosciences, Inc. announced the signing of an exclusive worldwide collaboration agreement to create, develop, manufacture, and commercialize IgM antibody agonists against…
Read More...

Eagle Pharmaceuticals, Inc. announced it has reached agreement on the terms of a transfer of the entire issued and to be issued share capital of Acacia Pharma Group plc to Eagle by way…
Read More...

Global biotherapeutics leader CSL Behring announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for etranacogene dezaparvovec…
Read More...

AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination, has been granted marketing authorisation in the European Union (EU) for the…
Read More...

Ligand Pharmaceuticals Incorporated (Ligand) announced the signing of a definitive merger agreement with Avista Public Acquisition Corp. II, a publicly traded special purpose…
Read More...